Bennett courtney (39 resultados)

Condición: New.

Paperback or Softback. Condición: New. Divorce Recovery: Divine Prayer Strategies to Experience God's Healing. Book.

Condición: As New. Unread book in perfect condition.

Condición: New.

Audio CD. Condición: Fine. This is an audio CD.

Soft cover. Condición: Very Good. Bottom of title page has stamp indicating that this issue was not accessioned by an academic library. Paginated 125-452, well illustrated. [b 726].

Paperback. Condición: Brand New. 309 pages. 8.00x5.25x0.78 inches. In Stock.

Condición: As New. Unread book in perfect condition.

Paperback. Condición: New. Brand new book, sourced directly from publisher. Dispatch time is 5-6 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Condición: New.

Paperback. Condición: Brand New. 520 pages. 8.00x5.00x1.18 inches. In Stock.

Paperback. Condición: Brand New. 141 pages. 11.00x8.50x0.36 inches. In Stock. Vickery, Courtney (ilustrador).

Taschenbuch. Condición: Neu. Neuware.

Condición: New. Print on Demand. Bennett Jr., John Wesley (ilustrador).

Condición: New.

Condición: New. In English.

Condición: New. 1st ed. 2022 edition NO-PA16APR2015-KAP.

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. The book opens with an overview of pharmacovigilance for cancer blockbuster drugs, covering both general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). A number of important examples of serious ADRs to hematology and oncology drugs are then reviewed, with evaluation of the lessons learned and the policy implications of the ensuing legal cases and their settlements. Further, the difficulty of reporting such blockbuster side effects in the medical literature is explored in an empirical study. Significant advances have been achieved in analytic methods for the identification of ADRs, and here there is a particular focus on the value of optimal discriminant analysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention - these fines are playing an important role in changing the landscape for pharmaceutical safety.…

Hardcover. Condición: new. Hardcover. This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. The book opens with an overview of pharmacovigilance for cancer blockbuster drugs, covering both general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). A number of important examples of serious ADRs to hematology and oncology drugs are then reviewed, with evaluation of the lessons learned and the policy implications of the ensuing legal cases and their settlements. Further, the difficulty of reporting such blockbuster side effects in the medical literature is explored in an empirical study. Significant advances have been achieved in analytic methods for the identification of ADRs, and here there is a particular focus on the value of optimal discriminant analysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention these fines are playing an important role in changing the landscape for pharmaceutical safety. This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. The book opens with an overview of pharmacovigilance for cancer blockbuster drugs, covering both general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). A number of important examples of serious ADRs to hematology and oncology drugs are then reviewed, with evaluation of the lessons learned and the policy implications of the ensuing legal cases and their settlements. Further, the difficulty of reporting such blockbuster side effects in the medical literature is explored in an empirical study. Significant advances have been achieved in analytic methods for the identification of ADRs, and here there is a particular focus on the value of optimal discriminant analysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention - these fines are playing an important role in changing the landscape for pharmaceutical safety.…

paperback. Condición: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardcover. Condición: Brand New. 1st edition. 167 pages. 9.50x6.50x0.75 inches. In Stock.

hardcover. Condición: Like New. Brand new gift quality hardcover in pictorial boards. Please email for photos. Larger books or sets may require additional shipping charges. Books sent via US Postal.

Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Bennett Jr., John Wesley (ilustrador).

Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Condición: new. Questo è un articolo print on demand.

Condición: new. Questo è un articolo print on demand.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. The book opens with an overview of pharmacovigilance for cancer blockbuster drugs, covering both general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). A number of important examples of serious ADRs to hematology and oncology drugs are then reviewed, with evaluation of the lessons learned and the policy implications of the ensuing legal cases and their settlements. Further, the difficulty of reporting such blockbuster side effects in the medical literature is explored in an empirical study. Significant advances have been achieved in analytic methods for the identification of ADRs, and here there is a particular focus on the value of optimal discriminant analysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention - these fines are playing an important role in changing the landscape for pharmaceutical safety. 167 pp. Englisch.…